By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Kiadis Pharma 

Zernikepark 6-8

Groningen    9747 AN  The Netherlands
Phone: 31-0-50-547-42-70 Fax: 31-0-50-547-42-71


SEARCH JOBS



Segment
Oncology





Company News
Kiadis Pharma Presents Positive Data From A Pre Specified Interim Analysis Of The Phase 2 Clinical Program With Its Lead Product ATIR 12/9/2014 9:24:07 AM
Kiadis Pharma's Lead Product ATIRâ„¢ Granted Orphan Drug Designation By European Medicines Agency For The Treatment Of Acute Myeloid Leukemia 10/30/2014 10:54:32 AM
Kiadis Pharma Appoints Jeroen Rovers As Its Chief Medical Officer 9/3/2014 11:29:45 AM
Kiadis Pharma Initiates Collaboration For Personalized Immunotherapies Using ATIRTM With Technische Universitat Munchen Within Munich Biotech Cluster 1/29/2014 9:20:00 AM
Kiadis Pharma Participates In Haploidentical Transplantation 2013 Forum 12/5/2013 6:22:55 AM
Kiadis Pharma Provides Positive Update On Its Phase II Clinical Program With Blood Cancer Treatment ATIR™ 11/18/2013 9:21:54 AM
Kiadis Pharma Secures Manufacturing Services Agreement for Its Phase II Clinical Program With Blood Cancer Treatment ATIR™ With the German Red Cross Blood Donor Service 10/7/2013 10:08:49 AM
Kiadis Pharma Secures Manufacturing Services Agreement for Its Phase II Clinical Program With Blood Cancer Treatment ATIR™ With the German Red Cross Blood Donor Service 10/7/2013 8:33:58 AM
Kiadis Pharma Completes Five-Year Follow-up of Its Phase I/II Clinical Study With Blood Cancer Product ATIR™ and Study Meets Primary Objective 9/11/2013 9:18:35 AM
Kiadis Pharma to Receive GMP Manufacturing License and GMP Certificate 7/23/2013 9:25:13 AM
1234
//-->